You are here
Home > 2019 > April > 17

QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (“C&GT”s), to be evaluated by GlaxoSmithKline’s C&GT platform group.

Press Release: 17 April 2019

QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (“C&GT”s), to be evaluated by GlaxoSmithKline’s C&GT platform group.

Polling Results Show Widodo Leading Indonesia Election

Polling groups said Wednesday that Indonesian President Joko Widodo is ahead in the country's presidential election.

The so-called quick counts based on data collected at polling stations showed Widodo about 10 percentage points ahead of challenger Prabowo Subianto.

Indonesia's Election …

Block China Mobile from US, FCC Chairman Says

SAN FRANCISCO The chairman of the top U.S. telecoms regulator on Wednesday announced his opposition to allowing China Mobile to operate in the United States, citing risks to American national security.

The statement from Federal Communications Commission Chairman Ajit Pai …

Top